Skip Content
You are currently on the new version of our website. Access the old version .

Toxins

Toxins is an international, peer-reviewed, open access journal related to toxinology and all kinds of toxins (biotoxins) from animals, microbes and plants, and published monthly online by MDPI. 
The French Society of Toxinology (SFET)International Society for Mycotoxicology (ISM)Japanese Society of Mycotoxicology (JSMYCO) and European Uremic Toxins (EUTox) Work Group are affiliated with Toxins and their members receive a discount on the article processing charges.
Indexed in PubMed | Quartile Ranking JCR - Q1 (Toxicology)

All Articles (7,677)

  • Systematic Review
  • Open Access

Hemodiafiltration (HDF) is increasingly used because of its enhanced theoretical clearance of diverse uremic toxins, particularly middle molecules and inflammatory cytokines, relative to conventional hemodialysis (HD), yet evidence on its biochemical benefits remains conflicting. Therefore, this meta-analysis was performed to evaluate the effects of HDF versus HD on uremic toxins, inflammation, anemia, and nutritional parameters. A systematic literature search was conducted using PubMed, Scopus, and the Cochrane Central Register of Controlled Trials to identify relevant studies. Only randomized controlled trials (RCTs) were included. Random-effects meta-analyses were performed to evaluate changes in the prespecified outcomes. Twenty-four RCTs involving 6072 dialysis patients were included. Compared with conventional HD, HDF was associated with significant reductions in serum phosphorus (weighted mean difference [WMD] −0.28 mg/dL; 95% CI −0.44 to −0.12) and β2-microglobulin (WMD −4.84 mg/dL; 95% CI −6.13 to −3.54). HDF also significantly reduced serum urea and C-reactive protein (CRP) levels, along with weekly erythropoietin requirements. Serum albumin levels were slightly but significantly lower in the HDF group than in the conventional HD group (WMD –0.06 g/dL; 95% CI −0.10 to −0.01); however, the clinical significance of such a difference remains uncertain. Higher convective volumes were identified as a key determinant of greater reductions in β2-microglobulin and CRP. Compared with conventional HD, HDF demonstrated superior reductions in several surrogate endpoints, including serum phosphorus, urea, β2-microglobulin, CRP, and weekly erythropoietin requirements. Reduced need for phosphate binders and anemia management may lower treatment-related costs.

6 February 2026

PRISMA 2020 flow diagram.

This study evaluated the occurrence of ochratoxin A (OTA) in Turkish coffee and its potential health implications under current consumption patterns by analyzing 65 ground and roasted Turkish coffee samples collected across Türkiye. OTA contamination was detected in 53 samples (82%). Based on the mean OTA concentration, the Estimated Daily Intake (EDI) was calculated as 0.1403 ng/kg body weight/day, and health risk characterization was performed using the Margin of Exposure (MOE) approach in accordance with the European Food Safety Authority (EFSA) recommendations for chronic exposure assessment. MOE calculations enabled a refined characterization of health risks under realistic (0.5 cup/day), average (1 cup/day), and high (3 cups/day) consumption scenarios. The MOE values for carcinogenic (neoplastic) effects ranged from 34,450 to 206,847, all exceeding the EFSA reference threshold of 10,000 and indicating a low level of concern for carcinogenic risk associated with Turkish coffee consumption. For non-carcinogenic (non-neoplastic) kidney effects, MOE values ranged from 11,238 to 67,475 across the different consumption scenarios, all exceeding the EFSA reference threshold of 200, indicating a low level of concern for the general population. In conclusion, the findings demonstrate that Turkish coffee consumption does not pose an OTA-related carcinogenic or non-neoplastic health risk for the general population under current consumption patterns. Nevertheless, considering the widespread consumption of Turkish coffee, continued monitoring and strict implementation of control measures throughout the production chain remain advisable to ensure long-term consumer safety.

6 February 2026

Histogram of OTA concentrations in Turkish coffee samples.

Alternative splicing of pre-mRNA is a crucial mechanism in gene expression regulation. As a core component of the spliceosome, the biological function of the Skip protein in Aspergillus flavus remains unknown. Quantitative real-time PCR (qPCR) analysis revealed the presence of two skip gene copies in A. flavus. Single-copy deletion of Skip resulted in slowed growth, reduced conidiation, abolished sclerotial formation, increased aflatoxin biosynthesis, and diminished crop colonization. Meanwhile, Skip was found to regulate the oxidative stress response by modulating the alternative splicing of yapA. Subsequently, immunoprecipitation and Western blot analyses identified lysine 325 (K325) as the benzoylated site on the Skip protein, which catalyzed by the acyltransferase EsaA. Mutation of benzoylated site K325 directly impaired fungal morphogenesis, pathogenicity, and stress adaptation. These findings established the crucial role of Skip and its benzoylation in A. flavus and suggested a potential target for controlling its infection in important crops.

6 February 2026

Skip plays an important role in fungal development. (A) Estimation of copy number of skip in A. flavus. The skipo and sumOo represent the initial copy numbers, and CN means copy number. (B) Expression level of skip on various development states in A. flavus (n = 3, * p < 0.05). VG, vegetative growth state; CON, conidiation state; SCR, sclerotium formation state; AFS, aflatoxin synthesis state. (C) Phenotype of WT, skip−/+ and skip-com strains on YGT media, after being grown for 7 days at 37 °C. Sclerotia were washed with 75% ethanol to remove mycelia. Sclerotia were observed at higher magnification. Bar = 0.5 cm. (D) Amount of sclerotia produced by different strains on YGT media (n = 3, ND is not detection). (E) Relative expression level of nsdC, nsdD and sclR genes (n = 3, * p < 0.05). (F) Phenotype of WT, skip−/+ and skip-com on YGT media, after being grown for 5 days at 37 °C. Microscopic observation of the conidiophores. Bar = 20 μm. (G,H) Colony diameter (G) and conidia production (H) by the different strains on YGT media (n = 5, * p < 0.05). (I) Relative expression level of abaA and brlA genes (n = 3, * p < 0.05).

ADP-Ribosylation of Cytidine: A Novel Nucleic Acid Modification Reversed by NADAR Hydrolases

  • Petra Mikolčević,
  • Andrea Hloušek-Kasun and
  • Andreja Mikoč
  • + 4 authors

ADP-ribosylation of nucleic acids is a modification found in both eukaryotes and bacteria, where it contributes to genome maintenance but can also serve as a toxic mechanism used by bacterial toxins to disrupt essential cellular processes. This modification is catalysed by ADP-ribosyltransferases and can be reversed by antagonistic ADP-ribosylgylcohydrolase enzymes. To date, ADP-ribosylation of nucleic acid bases has been described only for adenosine, guanosine, and thymidine. Here we report the ADP-ribosylation of cytidine, catalysed by members of the pierisin family of bacterial toxins—ScARP (SCO5461) and Scabin. We also show that ADP-ribosylation of cytidine is reversible through removal by certain NADAR family proteins, including NADAR proteins from the bacterium Streptomyces coelicolor (SCO5665) and the sponge Amphimedon queenslandica, as well as YbiA-type NADAR proteins. The conservation of cytidine de-ADP-ribosylating activity of NADAR proteins across phylogenetically distant species suggests that this modification may have important physiological significance.

6 February 2026

ScARP is a guanosine- and cytidine-modifying ADP-ribosyltransferase. (A–D) In vitro ADP-ribosylation activity assays were performed via polyacrylamide gel electrophoresis (denaturing conditions with 8 M urea) and stained with SYBR Gold. Non-modified oligonucleotides migrate faster than the ADP-ribosylated ones. (A) ScARP (0.1 µM) ADP-ribosylates multiple nucleotides in a single guanosine-containing oligonucleotide (ON). Enzymatically inactive mutant E164Q and absence of NAD+ were used as negative controls. (B) ScARP (1 µM) shows specificity for cytidine (C) and guanosine (G) and no activity on adenosine (A), deoxyuridine (U) or thymidine (T in the polyT backbone). (C) Incremental concentrations of ScARP assayed on single C- or G-containing ssDNA oligonucleotides (with polyT backbone). (D) ScARP is active on ssRNA containing cytidine and guanosine, but not on adenosine or uridine (backbone polyU) nucleotides. All panels show representative images from at least three independent experiments.

News & Conferences

Issues

Open for Submission

Editor's Choice

Reprints of Collections

Botulinum Toxin for Urinary Tract Disease
Reprint

Botulinum Toxin for Urinary Tract Disease

After a Decade from Approval
Editors: Heinrich Schulte-Baukloh
Botulinum Toxins
Reprint

Botulinum Toxins

New Uses in the Treatment of Diseases (2nd Edition)
Editors: Siro Luvisetto

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Toxins - ISSN 2072-6651